Overview

Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This study is designed to test the hypothesis that ecopipam is able to reduce urges to gamble in patients diagnosed with Pathological Gambling.
Phase:
Phase 2
Details
Lead Sponsor:
Psyadon Pharma
Treatments:
Ecopipam